QUATE Aptitude Test
The QUATE exam planned for Brussels on 7th September has been cancelled.
The next planned QUATE is in Malmo at the next EFECS meeting in June 2019.
The Exam comprises two components; written and practical
The pass mark for each section of the exam is as follows:
- Written 50%
- Screening test 75%
Candidates must pass both sections in order to be awarded an overall pass.
The examination papers will be marked on the day of the exam.
Successful candidates will receive their certificate on the day. Those that fail will receive feedback on where they failed.
Comprises Multiple Choice Questions only.
- 50 questions in one hour
- Choose the bestanswer from the five listed
- It is in your best interest to attempt ALL the questions.
- one mark for each correct answer
- zero for missing or incorrect answers.
The written paper is usually available in both English and the language of the host country.
There is a useful mock examination that sits on the Eurocytology website. Candidates can assess their competence using this. The link is: http://www.eurocytology.eu/en/quate
Please note the pass mark on the Eurocytology website is set at 80%. In the real exam it is 50%
- 16 slides to screen.
- Slides rotated every 10 minutes for conventional smears and 8 minutes for LBC. The slides will be screened in two batches of eight slides.
A refreshment break will be provided between the two screening sessions.
- You will not see the slide again once you have passed it on. Do not mark the slide in any way.
- You MUST choose ONE answer ONLY in the diagnostic category and mark this on the answer sheet.
- All slides are considered satisfactory for reporting.
- If HPV changes (koilocytosis) are present the slide must be called abnormal and graded accordingly.
- two marks for a correct answer
- zero for a missing answer, overcalling a negative slide or a major discrepancy in the grading of an abnormality (for instance LSIL called cancer)
- Some slides carry one mark for an almost correct grading such severe dyskaryosis calledLSIL or a glandular lesion called as squamous.
- Calling an abnormal slide normal (negative) will result in a minus score which means you will fail the exam.
- An overcall of a negative smear as abnormal in the screening test scores zero.
Repeated overcalling of negative slides is the most common reason for failing the screening test.
There is no exact syllabus for the QUATE examination, but candidates are expected to have a good understanding of the general principles and cytological findings found in the operation of a cervical cancer screening programme. This would include a knowledge and understanding of :
- the causesof cervical cancer
- principles of screening programmes with an emphasis on cervical screening programmes
- laboratory processing and handling of cervical cytology samples
- cytological reporting of cervical screening samples
- common infections and incidental findings identified in cervical screening samples
- the common histology and types of cervical cancer
- common treatment options for cervical cancer and FIGO staging
- relevant European guidance relating to cervical screening programmes
The above list is not exhaustive, but indicates the wide range of knowledge required for candidates for this examination. Standard text books will cover much of this, but web based resources such as :
EFCS : http://www.efcs.eu/
Reading of cytology journals, such as Cytopathology, can also help. See :http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2303